TY - JOUR
T1 - Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses
AU - Yolamanova, Maral
AU - Meier, Christoph
AU - Shaytan, Alexey K.
AU - Vas, Virag
AU - Bertoncini, Carlos W.
AU - Arnold, Franziska
AU - Zirafi, Onofrio
AU - Usmani, Shariq M.
AU - Müller, Janis A.
AU - Sauter, Daniel
AU - Goffinet, Christine
AU - Palesch, David
AU - Walther, Paul
AU - Roan, Nadia R.
AU - Geiger, Hartmut
AU - Lunov, Oleg
AU - Simmet, Thomas
AU - Bohne, Jens
AU - Schrezenmeier, Hubert
AU - Schwarz, Klaus
AU - Ständker, Ludger
AU - Forssmann, Wolf Georg
AU - Salvatella, Xavier
AU - Khalatur, Pavel G.
AU - Khokhlov, Alexei R.
AU - Knowles, Tuomas P.J.
AU - Weil, Tanja
AU - Kirchhoff, Frank
AU - Münch, Jan
PY - 2013/2/1
Y1 - 2013/2/1
N2 - Inefficient gene transfer and low virion concentrations are common limitations of retroviral transduction. We and others have previously shown that peptides derived from human semen form amyloid fibrils that boost retroviral gene delivery by promoting virion attachment to the target cells. However, application of these natural fibril-forming peptides is limited by moderate efficiencies, the high costs of peptide synthesis, and variability in fibril size and formation kinetics. Here, we report the development of nanofibrils that self-assemble in aqueous solution from a 12-residue peptide, termed enhancing factor C (EF-C). These artificial nanofibrils enhance retroviral gene transfer substantially more efficiently than semen-derived fibrils or other transduction enhancers. Moreover, EF-C nanofibrils allow the concentration of retroviral vectors by conventional low-speed centrifugation, and are safe and effective, as assessed in an ex vivo gene transfer study. Our results show that EF-C fibrils comprise a highly versatile, convenient and broadly applicable nanomaterial that holds the potential to significantly facilitate retroviral gene transfer in basic research and clinical applications.
AB - Inefficient gene transfer and low virion concentrations are common limitations of retroviral transduction. We and others have previously shown that peptides derived from human semen form amyloid fibrils that boost retroviral gene delivery by promoting virion attachment to the target cells. However, application of these natural fibril-forming peptides is limited by moderate efficiencies, the high costs of peptide synthesis, and variability in fibril size and formation kinetics. Here, we report the development of nanofibrils that self-assemble in aqueous solution from a 12-residue peptide, termed enhancing factor C (EF-C). These artificial nanofibrils enhance retroviral gene transfer substantially more efficiently than semen-derived fibrils or other transduction enhancers. Moreover, EF-C nanofibrils allow the concentration of retroviral vectors by conventional low-speed centrifugation, and are safe and effective, as assessed in an ex vivo gene transfer study. Our results show that EF-C fibrils comprise a highly versatile, convenient and broadly applicable nanomaterial that holds the potential to significantly facilitate retroviral gene transfer in basic research and clinical applications.
U2 - 10.1038/nnano.2012.248
DO - 10.1038/nnano.2012.248
M3 - Article
SN - 1748-3387
VL - 8
SP - 130
EP - 136
JO - Nature Nanotechnology
JF - Nature Nanotechnology
IS - 2
ER -